Technical Analysis for AVDL - Avadel Pharmaceuticals plc

Grade Last Price % Change Price Change
grade D 8.36 -1.42% -0.12
AVDL closed down 1.42 percent on Friday, August 7, 2020, on 70 percent of normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical AVDL trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Earnings Movers Other 0.00%
Pocket Pivot Bullish Swing Setup -1.42%
Bollinger Band Squeeze Range Contraction -1.42%
BB Squeeze + Upper Band Touch Range Contraction -1.42%
Upper Bollinger Band Touch Strength -1.42%
20 DMA Support Bullish 1.46%
50 DMA Support Bullish 1.46%
MACD Bullish Centerline Cross Bullish 1.46%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avadel Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, France, and Ireland. The company primarily develops FT218, which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) and cataplexy. It also markets three sterile injectable drugs used in the hospital setting, including Akovaz that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia; Bloxiverz, a cholinesterase inhibitor indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery; and Vazculep, a phenylephrine hydrochloride injection indicated for the treatment of clinically important hypotension. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
Pharmaceutical Organ Systems Drugs Surgery Psychoactive Drugs Sleep Disorders Phenols Amines Narcolepsy Cataplexy

Is AVDL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.49
52 Week Low 1.82
Average Volume 584,136
200-Day Moving Average 7.65
50-Day Moving Average 8.25
20-Day Moving Average 8.20
10-Day Moving Average 8.23
Average True Range 0.51
ADX 8.62
+DI 18.97
-DI 17.56
Chandelier Exit (Long, 3 ATRs ) 7.55
Chandelier Exit (Short, 3 ATRs ) 8.98
Upper Bollinger Band 8.73
Lower Bollinger Band 7.67
Percent B (%b) 0.65
BandWidth 12.92
MACD Line 0.03
MACD Signal Line 0.00
MACD Histogram 0.0342
Fundamentals Value
Market Cap 335.1 Million
Num Shares 40.1 Million
EPS 0.95
Price-to-Earnings (P/E) Ratio 8.80
Price-to-Sales 2.18
Price-to-Book 4.94
PEG Ratio 0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.80
Resistance 3 (R3) 8.80 8.66 8.72
Resistance 2 (R2) 8.66 8.55 8.66 8.70
Resistance 1 (R1) 8.51 8.48 8.44 8.51 8.67
Pivot Point 8.37 8.37 8.34 8.37 8.37
Support 1 (S1) 8.22 8.26 8.15 8.22 8.05
Support 2 (S2) 8.08 8.19 8.08 8.02
Support 3 (S3) 7.93 8.08 8.00
Support 4 (S4) 7.93